Next, we investigated whether the HGF/Met pathway is involved in renal fibrosis in DN patients using immunofluorescence staining with a phosphorylation-specific cMet antibody (Ab) to determine the levels of active cMet. Here, MET is linked to liver dysplastic nodule.